VanEck Biotech ETF
BBH
BBH
110 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $125M → $123M (-$2.23M)
13% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 24
Holders
110
Holding in Top 10
1
Calls
$2.41M
Puts
$1.19M
Top Buyers
| 1 | +$11.5M | |
| 2 | +$3.93M | |
| 3 | +$1.83M | |
| 4 |
CCA
Conservest Capital Advisors
Wynnewood,
Pennsylvania
|
+$729K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$667K |
Top Sellers
| 1 | -$5.03M | |
| 2 | -$1.9M | |
| 3 | -$1.1M | |
| 4 |
LPL Financial
San Diego,
California
|
-$1.01M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$690K |
